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Abstract
Cross-talk between DNA methylation and histone modifications drives the establishment 
of composite epigenetic signatures and is  traditionally studied using correlative rather 
than direct approaches. Here we present sequential ChIP-bisulfite-sequencing (ChIP-
BS-seq) as an approach to quantitatively assess DNA methylation patterns associated 
with chromatin modifications or chromatin-associated factors directly. A chromatin-
immunoprecipitation (ChIP)-capturing step is used to obtain a restricted representation 
of the genome occupied by the epigenetic feature of interest, for which a single-base 
resolution DNA methylation map is then generated. When applied to H3 lysine 27 tri-
methylation (H3K27me3), we found that H3K27me3 and DNA methylation are 
compatible throughout most of the genome, except for CpG islands, where these two 
marks are mutually exclusive. Further ChIP-BS-seq-based analysis in Dnmt triple-
knock-out (TKO) embryonic stem cells revealed that total loss of CpG methylation is 
associated with alteration of H3K27me3 levels throughout the genome: H3K27me3 in 
localized peaks is decreased while broad local enrichments (BLOCs) of H3K27me3 are 
formed. At an even broader scale, these BLOCs correspond to regions of high DNA 
methylation in wild-type ES cells, suggesting that DNA methylation prevents H3K27me3 
deposition locally and at megabase scale. Our strategy provides an unique way of 
investigating global interdependencies between DNA methylation and other chromatin 
features.
Supplementary data available for this manuscript: 
Supplementary Figures 1 to 8, Supplementary Table S1 & S2, GEO Series accession number 
GSE28254
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Introduction
Epigenetic regulation, involving DNA methylation and histone modifications, is 
fundamental to a multitude of biological processes such as transcription, DNA replication and 
repair. The different modifications do not act independently of each other. Instead, cross-talk 
between different modifications plays an important role in establishment of chromatin 
diversity within the genome. Interdependent deposition and mutual exclusion of various 
marks result in complex modification patterns with different functional outcomes (Cedar and 
Bergman 2009; Fischle 2008; Jung-Shin Lee et al. 2010). Classically, such patterns are 
determined by parallel genomic mapping of the various modifications within the same 
samples, using chromatin immunoprecipitation and deep sequencing (ChIP-seq, Barski et al. 
2007; Mikkelsen et al. 2007). However, the analysis of cross-talk through independent 
profiling experiments is complicated by cell population heterogeneity, cell cycle effects, and 
allele-specific marking of chromatin such as in imprinting or X-inactivation.
Here we present a method for the integrated analysis of histone modification or 
transcription factor deposition patterns and the underlying DNA methylation. In our approach, 
termed ChIP-BS-seq, ChIP capturing is followed by bisulfite conversion and deep sequencing 
to directly assess DNA methylation levels in captured chromatin fragments. While the use of 
whole-genome bisulfite shotgun sequencing is limited by the cost of the required sequencing 
depth, a restricted genomic representation obtained by ChIP capturing allows to reach 
adequate coverage at routine-scale sequencing, providing increased quantitative accuracy of 
DNA methylation measurements within captured regions.
We used ChIP-BS-seq to study the global cross-talk between H3K27me3 and DNA 
methylation, which are both linked to repression. Polycomb Repressive Complex 2 (PRC2) 
catalyzes H3K27me3 methylation via the SET domain of EZH2, while Polycomb Repressive 
Complex 1 (PRC1) is recruited to the H3K27me3 mark and is involved in gene silencing 
(Simon and Kingston 2009). The DNA methyltransferases DNMT3A/B and DNMT1 are 
responsible for the establishment and maintenance of the DNA methylation mark, 
respectively (Cedar and Bergman 2009). The interplay between DNA methylation and 
H3K27me3/Polycomb has been subject to extensive studies, and different phenomena have 
been described (Cedar and Bergman 2009). Direct interactions between Polycomb and the 
DNA methylation machinery have been reported, suggesting that H3K27me3 and DNA 
methylation co-occur (Viré et al. 2006). Co-occurrence was further supported by ChIP 
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experiments analyzing DNA hypermethylated promoters in cancer cells (McGarvey et al. 
2006; Schlesinger et al. 2007). Whereas H3K27me3 has been shown to 'prime' gene 
promoters for later DNA methylation (Schlesinger et al. 2007; Mohn et al. 2008; 
Widschwendter et al. 2007; Ohm et al. 2007; Gal-Yam et al. 2008), several reports have 
shown antagonism or mutual exclusiveness between H3K27me3 and DNA methylation (Wu 
et al. 2010; Lindroth et al. 2008; Bartke et al. 2010; Kondo et al. 2008). Although the different 
observations are not necessarily incompatible, the co-occurrence of both marks is still a 
subject of debate. Using ChIP-BS-seq we addressed the overlap of H3K27me3 and DNA 
methylation directly on a genome-wide scale. Our results unequivocally show that DNA 
methylation and H3K27me3 generally co-occur, but are mutually exclusive in CpG-dense 
regions. This mutual exclusivity is found in both a cancer cell line as well as in mouse ES 
cells. Loss of DNA methylation in ES cells is associated with the formation of H3K27me3 
patterns previously described as broad local enrichments (BLOCs), and at an even larger 
scale, H3K27me3 appears in megabase-sized regions that were marked by high DNA-
methylation in wild-type cells.
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Results
Establishment of the strategy
An outline of our strategy, which we named ChIP-BS-seq, is shown in Figure 1A. 
ChIP is used to capture a genomic sub-fraction associated with a specific histone modification 
or transcription factor. Similarly, such sub-fraction can be obtained by capture of methylated 
DNA using a methyl-CpG binding domain (MBD). Captured DNA fragments are subjected to 
end-repair, adapter ligation using methylated adapters, bisulfite conversion, PCR-
amplification, and deep-sequencing (Fig. 1A). In this way the levels of DNA methylation can 
be quantitatively assessed at base-resolution within the genomic sub-fraction of interest. 
To provide technical proof-of-principle of our strategy we used capturing of 
methylated DNA by MethylCap (Brinkman et al. 2010; Bock et al. 2010), followed by 
bisulfite-deep sequencing (MethylCap-BS-seq). In MethylCap, an MBD domain is used to 
capture methylated DNA (Brinkman et al. 2010). Genomic DNA isolated from normal and 
tumor colon tissues was used for MethylCap-BS-seq as well as for conventional MethylCap-
seq experiments. Sequence reads were mapped as described in Methods (see also Suppl. Table 
1). Read densities across the entire genome of MethylCap and MethylCap-BS-seq 
experiments correlated well (Pearson R = 0.833, Suppl. Fig. 1A), which is comparable to 
technical replicates of conventional MethylCap samples (Pearson R ≤ 0.85, unpublished). 
This indicated that the same genomic sub-fraction was captured and sequenced in both 
procedures. Within each sequencing read, cytosines within a CpG context were scored for 
their methylation status by counting the percentage of bisulfite-induced mutations. As a 
control for bisulfite conversion efficiency we assessed DNA methylation within 
mitochondrial DNA which was present at low levels due to its cellular abundance. 
Mitochondrial DNA is known to be completely unmethylated, and conversion was calculated 
to be 99.91%. In addition, efficient conversion of 99.7% was found in genomic CHG/CHH 
context.
Next, we focused on the captured genomic sub-fraction. Visual inspection of 
individual peaks showed that they were mostly hypermethylated (Fig. 1B and Suppl. Fig. 1B). 
This was confirmed on a global scale (Fig. 1C); mean methylation was 87% within 
MethylCap peaks. At boundaries, methylation showed a sharp drop that continued further 
with increasing distance from peaks. This was accompanied by decreases in read densities and 
thus CpG coverage. When focused exclusively on regions inside the MethylCap peaks we 
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found that 85% and 79% of the CpGs were at least 80% methylated in normal and tumor, 
respectively (Suppl. Fig. 1C). 
Differential methylation between normal and tumor as observed by conventional 
MethylCap-seq was confirmed by MethylCap-BS-seq; differentially methylated regions 
showed corresponding alterations in CpG coverage and absolute CpG methylation (Fig. 1B, 
bottom panel, Suppl. Fig. 1B, middle panel). The same was observed on a global scale: 
regions that gained DNA methylation in tumor compared to normal tissue (color-coded in Fig. 
1D) showed increased coverage and methylation levels in MethylCap-BS-seq, whereas the 
opposite was observed for regions that lost methylation. Taken together, MethylCap-BS-seq 
showed hypermethylation of MethylCap-captured DNA, and differences observed between 
normal and tumor tissue could be corroborated and extended using MethylCap-BS-seq. These 
experiments demonstrate the successful integration of capturing experiments with bisulfite 
deep sequencing. 
H3K27me3-ChIP-BS-seq
We next applied our approach to ChIP-captured DNA (ChIP-BS-seq) for analysis of 
DNA methylation patterns associated with specific chromatin modifications. H3K27me3 and 
DNA methylation are both involved in gene silencing, but their interplay is under debate and 
has not been directly investigated. We performed ChIP-BS-seq on H3K27me3, using HCT116 
colon carcinoma cells. For comparison we also generated conventional ChIP-seq profiles for 
H3K27me3. Read densities of the conventional H3K27me3 ChIP-seq and ChIP-BS-seq 
experiments correlated well (Pearson R = 0.854, Suppl. Fig. 2A), showing that the 
bisulfite/mapping procedure did not alter the H3K27me3 patterns. The H3K27me3 genome-
wide profile showed H3K27me3 enrichments over broad regions, comprising genes and 
intergenic regions (Fig. 2A, Suppl. Fig. 2C, Suppl. Fig. 3C). This pattern resembled the 
H3K27me3 'BLOCs' profile in mouse and human fibroblast cells (Pauler et al. 2009; Hawkins 
et al. 2010), and differs from H3K27me3 patterns in mouse ES cells, where the mark is 
present in focal areas at silent promoters (Mikkelsen et al. 2007; Pan et al. 2007; Xiao Dong 
Zhao et al. 2007; Marks et al. 2009) (see also below). As described before, genes that were 
located within the H3K27me3 BLOCs were generally silent, whereas genes outside BLOCs 
had a significant higher average expression level (Suppl. Fig. 3A). 
To rule out that crosslinking/de-crosslinking of chromatin interfered with bisulfite 
conversion, we performed bisulfite sequencing on 12 independent PCR fragments amplified 
from genomic DNA isolated directly or after crosslinking/de-crosslinking (Suppl. Fig. 2B). 
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None of the fragments showed altered DNA methylation patterns after crosslinking/de-
crosslinking, showing that ChIP-derived DNA did not affect bisulfite conversion.
DNA hypomethylation in H3K27me3-enriched high CpG density regions
 We then interrogated the DNA methylation status of captured H3K27me3-marked 
chromatin. H3K27me3-marked chromatin coincided mostly with fully methylated CpGs, with 
smaller patches of lower methylation occurring in between (Fig. 2A, Suppl. Fig. 2C). 
Strikingly, CpG-rich promoter regions marked with H3K27me3 contained exclusively 
unmethylated CpGs. For example, the SERTAD4, SMAD7 and OVOL2 genes were located 
within H3K27me3 BLOCs (Fig. 2B and Suppl. Fig. 2D) and were mostly DNA methylated, 
except for the CpG islands encompassing their gene promoters; these were completely 
hypomethylated. 
To analyze DNA methylation of the H3K27me3-enriched fraction on a genome-wide 
scale, DNA methylation was determined in 300-bp windows throughout H3K27me3 BLOCs, 
and windows were subsequently categorized according to their genomic function (intergenic, 
intron, exon, non-CpG island promoter, CpG island promoter). Histograms displaying DNA 
methylation levels are shown in Fig. 2C. Within a window size of 300 bp, the DNA 
methylation pattern was clearly bimodal, as shown previously (Meissner et al. 2008). Genes, 
intergenic regions and non-CpG island promoters enriched for H3K27me3 generally 
contained unmethylated as well as methylated DNA, although methylated DNA was 
prevalent. In contrast, CpG island promoters marked with H3K27me3 contained only 
hypomethylated DNA. Since this exclusively applied to CpG island containing promoters, we 
also categorized windows according to CpG density (Suppl. Fig. 2E). While low-CpG dense 
windows (<0.06 CpGs/bp) contained mostly DNA hypermethylation, high CpG-density 
windows (>0.06 CpGs/bp) were exclusively hypomethylated. We next focused in more detail 
on H3K27me3-captured CpG islands. Median DNA methylation from 5 kb outside to 0.5kb 
within these CpG islands was plotted along with CpG-density and H3K27me3 levels (Fig. 
2D). A clear and sharp decrease in DNA methylation took place at CpG island borders, 
resulting in an almost perfect inverse correlation between DNA methylation and CpG-density. 
Inside CpG islands H3K27me3 was consolidated. Taken together, our results show that 
H3K27me3 and DNA methylation generally co-occur in low CpG-density regions, i.e. the 
bulk of the human genome. Within H3K27me3-marked regions of high CpG-density, such as 
CpG islands, DNA is exclusively hypomethylated. We conclude that H3K27me3 and DNA 
methylation are mutually exclusive in CpG-dense regions.       
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Hypermethylated CpG islands show local H3K27me3 depletion within H3K27me3 
BLOCs
The results obtained by H3K27me3 ChIP-BS-seq clearly demonstrate the existence of 
mutual exclusiveness of H3K27me3 with DNA methylation in CpG islands. To further 
confirm the relevance of this observation, we analyzed genome-wide profiles for H3K27me3 
and DNA methylation generated by conventional ChIP-seq and MethylCap-seq. Using this 
approach we could test whether DNA methylation also excludes H3K27me3. Obviously, the 
latter could not be directly shown by ChIP-BS-seq as regions lacking H3K27me3 were not 
captured and thus not available for DNA methylation measurements. 
To test our hypothesis we examined DNA-methylated CpG islands within H3K27me3 
BLOCs. We detected 6,456 H3K27me3 BLOCs with a median length of 77 kb (Suppl. Fig. 
3B). 8,781 out of the total 28,226 annotated CpG islands (31%, http://genome.ucsc.edu/) were 
located within H3K27me3 BLOCs. 6,473 of these CpG islands contained MethylCap peaks. 
Visual inspection of such methylated CpG islands within H3K27me3 BLOCs revealed local 
depletions of H3K27me3 (Fig. 3A and Suppl. Fig. 3C). To assess this at a genome-wide scale, 
we generated density maps  representing read densities of MethylCap and H3K27me3 ChIP 
around BLOCs-contained methylated CpG islands (Fig. 3B). A clear local depletion of 
H3K27me3 was evident over methylated CpG islands. To exclude that this local depletion of 
H3K27me3 was due to a local drop in nucleosome density, we used publicly available DNaseI 
hypersensitivity data from HCT116 cells (ENCODE). MethylCap peaks were not enriched for 
DNaseI hypersensitivity, and are thus unlikely to represent nucleosome-depleted regions 
(Suppl. Fig. 3D). Taken together, our data show that DNA-hypermethylated CpG islands 
present within H3K27me3 BLOCs are locally depleted for H3K27me3. This corroborates and 
extends the above findings on mutual exclusiveness of DNA methylation and H3K27me3 in 
regions of high CpG density.
Mutual exclusiveness of H3K27me3 and DNA methylation in mouse ES cells
To extend our observations to non-cancerous cells, we applied our H3K27me3-ChIP-
BS-seq strategy to mouse embryonic stem (mES) cells. Regions of H3K27me3 enrichment 
were smaller than in HCT116, representing the typical more peak-like mES pattern described 
before (Mikkelsen et al. 2007; Pan et al. 2007; Xiao Dong Zhao et al. 2007; Marks et al. 
2009) (Fig. 4A and Suppl. Fig. 4A). About one third of these H3K27me3 peaks overlap with 
CpG islands or transcription start sites encompassing CpG islands (32%, Suppl. Fig. 4B). 
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Importantly and as in HCT116 cells, these CpG-rich regions contained exclusively 
unmethylated CpGs. For example, the Htra4/Plekha2, and Lmx1b genes were mostly DNA 
methylated, except for the CpG islands underneath the H3K27me3 peaks (Fig. 4A). We 
generated average profiles for H3K27me3 peaks over CpG islands and accompanying DNA 
methylation from H3K27me3-ChIP-BS-seq (Fig. 4B). Whereas DNA methylation on the 
flanks of CpG islands was 80%, this dropped to zero in CpG islands. This decrease appeared 
to be instigated at least 0.5 kb away from CpG islands, where CpG density is elevated but by 
far not maximal. To further relate DNA methylation–H3K27me3 mutual exclusiveness to 
high CpG density, we applied a 300-bp sliding window approach over all H3K27me3 peaks, 
categorized these windows according to their CpG density, and inferred their DNA 
methylation status from the ChIP-BS-seq data (Fig. 4D). Up to a CpG density of 0.05 
CpG/bp, H3K27me3 and DNA methylation co-occurred within the same windows. This CpG 
density corresponds to that encountered at the borders ('shores')  of CpG islands 
(http://genome.ucsc.edu/). Within windows of higher CpG density (>0.05 CpG/bp) DNA 
methylation was virtually absent, confirming the antagonism between H3K27me3 and DNA 
methylation. Together, these data clearly confirm and extend our findings on mutual 
exclusiveness of DNA methylation and H3K27me3 in regions of high CpG density to mES 
cells. 
As an extension to  our  observations  with H3K27me3,  we performed ChIP-BS-seq 
using H3K9me3, a repressive mark that has classically been linked to DNA hypermethylation. 
Indeed, examples of H3K9me3 peaks such as in the imprinting control region (ICR) upstream 
from H19 (Bell and Felsenfeld 2000; Hark et al. 2000; Kanduri et al. 2000) showed that this 
mark  was  associated  with  hypermethylated  DNA in  mES  cells  (Suppl.  Fig.  5A).  Of  all 
detected H3K9me3 peaks,  over 90 percent of them were associated with hypermethylated 
DNA (Suppl. Fig. 5B). This is in sharp contrast with H3K27me3 peaks, under which there is a 
more  equal  subdivision  of  hypomethylated  and  hypermethylated  DNA (Suppl.  Fig.  5B), 
corresponding to high-CpG density and low-CpG density sequences, respectively (see Fig. 
4D). These data show that histone marks other than H3K27me3 may display different DNA 
methylation properties, which extends and confirms the validity of the ChIP-BS-seq strategy.
H3K27me3 changes upon loss of DNA methylation
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We next addressed the question what happens to the  H3K27me3 distribution upon 
removal of DNA methylation. Therefore we performed H3K27me3-ChIP-BS-seq on 
Dnmt[1kd,3a-/-,3b-/-] (TKO) mES cells (Meissner et al. 2005). DNA methylation in virtually 
all of the captured/sequenced CpGs had disappeared (Suppl. Fig. 5B). 
We first focused on CpG islands and created average profiles for H3K27me3 peaks 
over CpG islands (Fig. 4C). DNA methylation had disappeared, and the H3K27me3 signal 
over CpG islands that was generally high in wild-type cells had also decreased in TKO cells. 
It should be noted that hypermethylated CpG island in wild-type mES cells are scarce and not 
captured by H3K27me3 ChIP due to the observed antagonism, so their contribution to these 
average profiles is almost zero. To enable analysis of H3K27me3 changes in hypermethylated 
CpG islands we subselected such CpG islands using publicly available data (Stadler et al. 
2011) and plotted the changes in H3K27me3 from conventional ChIP data. In case of 
antagonism between DNA methylation and H3K27me3 we expected that hypermethylated 
CpG islands would gain H3K27me3 in TKO cells, which was indeed the case (Fig. 4E). The 
opposite effect, although to a lesser magnitude, occurred at hypomethylated CpG islands. 
These CpG islands – containing high H3K27me3 – displayed a loss in H3K27me3 in TKO 
cells (Fig. 4E). Thus,  antagonism between DNA methylation and H3K27me3 was clearly 
observed in hypermethylated CpG islands, but appeared to be absent in unmethylated CpG 
islands, where loss of DNA methylation caused a concomitant decrease of H3K27me3.
The H3K27me3 changes described above concern mainly the sharp and localized 
peaks of H3K27me3 typical of mES cells. An additional and striking observation in TKO 
cells was the appearance of large regions of H3K27me3 enrichment, resembling the typical 
BLOCs (Fig. 5A). To analyze the co-occurring changes of peaks and BLOCs in more detail, 
we plotted the fold change of H3K27me3 BLOCs against the fold change of the localized 
peaks within these BLOCs (Fig. 5B). In 43% of the cases, the increase in H3K27me3 in 
BLOCs was accompanied by a decrease of H3K27me3 in localized peaks within the same 
BLOCs (Fig. 5B, quadrant II). In another 18% of the cases, BLOCs appeared but the peaks of 
H3K27me3 in these BLOCs were maintained (Fig. 5B, quadrant I). The observed changes of 
H3K27me3 in TKO cells  – decrease in peaks and accumulation in BLOCs –  could be clearly 
confirmed using targeted ChIP-qPCR. 10 out the 12 tested peaks showed decrease and 8 out 
of the 9 tested BLOCs showed increase (Suppl. Fig. 6). These results not only validated our 
genome-wide analyses, but also excluded the possibility that decrease of H3K27me3 peaks 
was a technical artifact due to a higher complexity of the TKO sequencing libraries by 
accumulation of H3K27me3 throughout a larger part of the genome. 
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A  possible  explanation  for  accumulation  of  H3K27me3  BLOCs  could  be  a 
compensatory repressive effect instigated by the loss of DNA methylation. If this were the 
case, H3K27me3 BLOCs elevated in TKO cells are expected to represent genomic regions 
with high DNA methylation in wild-type cells. We made use of our H3K27me3-ChIP-BS-seq 
data to assess the DNA methylation status in TKO-BLOC regions in wild-type cells (Fig. 5C). 
Indeed, in cases where BLOCs became more prominent (Fig. 5C, quadrants I & II), DNA 
methylation in wild-type mES cells was significantly higher as compared to regions where 
H3K27me3 was lost (Fig. 5C, quadrants I vs. IV, p = 2.8e-68; quadrants II vs. III, p = 1.5e-
137 , Mann–Whitney U test).  These data suggest that large chromosomal regions with high 
DNA methylation become more susceptible for accumulation of H3K27me3 upon removal of 
DNA methylation. To analyze H3K27me3 changes instigated by loss of DNA methylation at 
an even larges scale and independent of BLOC-like patterns, we generated a MethylCap DNA 
methylation profile for wild-type mES cells. A sliding window of 0.5 Mb was applied (Suppl. 
Fig. 7A). We found that H3K27me3 in TKO cells resembled the MethylCap profile of wild-
type (Suppl.  Fig.  7B).  Correlation between H3K27me3 and MethylCap profiles  increased 
from 0.41 in wild-type to 0.71 in TKO (Pearson correlation, Suppl. Fig. 7C). 
To analyze the consequence – if any – of H3K27me3 accumulation in BLOCs at the 
level of gene expression, we categorized RefSeq genes according to their position within or 
outside BLOCs and plotted their expression levels in wild-type and TKO cells (RNA-seq data 
from  Karimi et al. 2011). Genes located outside BLOCs were expressed at higher levels than 
genes located within BLOCs (Suppl. Fig. 8A), which is in line with observations made by 
others (Pauler et al. 2009) and us in HCT116 cells (see Suppl. Fig. 3A). Strikingly, in wild-
type  mES  cells  these  differences  were  already  evident,  even  though  BLOCs  are  less 
prominent as in TKO cells. As shown before (Karimi et al. 2011), loss of DNA methylation 
did not  cause  massive deregulation,  and the  expression levels  of  most  genes  were  stably 
maintained. Only 190 transcripts were found to be deregulated (Suppl. Fig. 8B, FDR of 0.05, 
minimal 2-fold change). 
A closer inspection of H3K27me3 patterns in wild-type mES cells revealed that 
BLOCs of TKO cells could already be distinguished in wild-type cells, although signals were 
much weaker (Fig. 5A). This was confirmed by plotting density maps of all BLOC transition 
regions in both wild-type and TKO cells (Fig. 5D): the same BLOC boundaries were present 
in wild-type cells as in TKO cells. Taken together, total removal of DNA methylation caused 
an accumulation of H3K27me3 signal in BLOC-like patterns with boundaries that  had been 
set in wild-type cells. This suggests that besides the local antagonism between the two marks 
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at high-CpG dense regions, there is also antagonism between the two marks at a much larger 
scale in the genome.
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Discussion 
Various methods for the generation of genome-wide DNA methylation maps exist. An 
extensive comparison of the most frequently used bisulfite- and enrichment-based 
technologies has recently been performed (Bock et al. 2010; Harris et al. 2010). In our 
strategy, we integrated MethylCap and ChIP-capturing procedures with bisulfite-based DNA 
methylation analysis. Although similar strategies have been used to interrogate DNA 
methylation within a limited number of preselected regions (Thomson et al. 2010; Kagey et 
al. 2010), our strategy allows to obtain base-resolution DNA methylation information within 
all fragments obtained by a capturing step. Any subset of the genome occupied by a specific 
feature can be directly assessed for DNA methylation, provided that the feature of interest can 
be enriched for or captured. Not only does this open up the possibility to assess cross-talk 
between DNA methylation and other chromatin features, it also allows for the analysis of 
DNA methylation within binding sites of transcription factors that are dependent or excluded 
by DNA methylation. In addition, it allows for detection of allele-specific marking of 
chromatin such as in imprinting or X-inactivation. 
We used MethylCap-BS-seq as a proof-of-principle for our strategy and showed that 
DNA fragments obtained by MethylCap represent a highly methylated fraction of the genome. 
In addition, differences in methylation between normal and tumor tissue as detected by 
conventional MethylCap-seq were corroborated and extended by MethylCap-BS-seq. ChIP-
BS-seq was successfully established using H3K27me3 and H3K9me3 as the epigenetic marks 
of interest. Depending on CpG density, H3K27me3 and DNA methylation  co-occur or are 
mutual exclusive, whereas H3K9me3 and DNA methylation coincide. 
Upon loss of DNA methylation in TKO cells we observed two notable effects, (1) 
accumulation of H3K27me3 in BLOC patterns and (2) a decrease (flattening) of sharp 
localized H3K27me3 peaks. Thus,  depending on whether  one  regards  BLOCs or  smaller 
peaks, the effects of DNA methylation loss appear to be different. Our data strongly suggest 
that the increase in H3K27me3 BLOCs  is related to antagonism between H3K27me3 and 
DNA methylation, since regions where H3K27me3 accumulates in BLOC patterns have 
elevated methylation already in wild-type mES cells. Decrease of H3K27me3 in peaks occurs 
mostly  in  unmethylated  CpG  islands;  likely  surrounding  DNA  methylation  normally 
constraints H3K27me3 to unmethylated CpG islands in wild-type cells, which is lost in TKO 
cells. This constraint probably relates to the same antagonism as observed elsewhere in the 
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genome  and  as  such  limits  the  spread  of  H3K27me3  into  neighboring  chromatin.  Thus, 
although the H3K27me3 changes observed in BLOCs and peaks are different, they may result 
from the same antagonism between DNA methylation and H3K27me3. We have ruled out that 
the  decrease in peaks  is a technical artifact caused by increased complexity of sequencing 
libraries as a larger part of the genome is enriched for H3K27me3 (Suppl. Fig. 6). 
How the observed mutual exclusiveness of H3K27me3 and DNA methylation within 
regions of high CpG density is achieved mechanistically is not yet clear, but several studies 
have described an antagonism between H3K27me3 and DNA methylation. In SILAC 
nucleosome affinity purifications, DNA methylation of nucleosome positioning sequences 
impeded PRC2 binding to H3K27me3-modified nucleosomes (Bartke et al. 2010). The CpG 
density of the nucleosome positioning sequences (“601” and “603”) was 0.09 CpG/bp. At this 
density we observed mutual exclusiveness of the H3K27me3 and DNA methylation marks in 
both HCT116 as well as in mES cells (see Suppl. Fig. 2E and Fig. 4D). Therefore, one 
explanation for our observations may be obstruction of PRC2 recruitment at DNA methylated 
CpG-dense regions. Such obstruction may also be involved in epigenetic switching as 
described for prostate cancer cells (Gal-Yam et al. 2008). Genes initially silenced by 
Polycomb in normal prostate cells, acquired DNA methylation and lost H3K27me3 in the 
PC3 cancer cells. 
The appearance of H3K27me3 BLOCs in TKO cells suggests that DNA methylation 
more globally antagonizes accumulation of H3K27me3, which is alleviated in TKO cells. 
Still, the resulting BLOCs occur in specific genomic regions that importantly are pre-set in 
wild-type mES cells, indicating that there are positional restraints on the deposition of 
H3K27me3. It is possible that these regions and their boundaries are characterized by other 
(epi)genetic features such as over-representation of genomic elements like certain repeat 
classes, CpG islands, gene density, lamina-associated domains (Guelen et al. 2008) or 
transcriptional factor binding. We anticipate that the two-dimensional information obtained 
using ChIP-BS-seq will provide new insights in the composition of different types of 
chromatin and their biological roles.
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Methods
ChIP-seq, MethylCap-seq and RNA-seq
HCT116 cells were cultured in McCoy’s 5A medium supplemented with 10% fetal 
bovine serum and 1% penicillin/streptomycin (all Gibco/Invitrogen) at 37 °C in 5% CO2 
atmosphere. Mouse ES cells were cultured as described in (Meissner et al. 2005). Chromatin 
harvesting and ChIPs were performed as described (Denissov et al. 2007). The following 
antibodies were used: anti-H3K27me3 (Millipore, 07-449) (Peters et al. 2003) and anti-
H3K4me3 (Diagenode). MethylCap-seq was performed as described (Brinkman et al. 2010). 
For RNA-seq total RNA was isolated using Trizol (Invitrogen) according to the 
manufacturer's recommendations. 100µg total RNA was subjected to two rounds of poly(A) 
selection (Oligotex mRNA Mini Kit, QIAGEN), followed by DNaseI treatment (QIAGEN). 
100 ng mRNA was fragmented by hydrolysis (5x fragmentation buffer: 200mM Tris acetate, 
pH8.2, 500mM potassium acetate and 150mM magnesium acetate) at 94°C for 90 s and 
purified (RNeasy MinElute Cleanup Kit, QIAGEN). cDNA was synthesized using 5µg 
random hexamers by Superscript III Reverse Transcriptase (Invitrogen). ds-cDNA synthesis 
was performed in second strand buffer (Invitrogen) according to the manufacturer's 
recommendations and purified (MinElute Reaction Cleanup Kit, QIAGEN). ChIP and 
MethylCap DNA and ds-cDNA were prepared for Illumina sequencing according to 
manufacturer's protocols (Illumina). 
ChIP-BS-seq and MethylCap-BS-seq
100 ng ChIP DNA or 10 ng MethylCap DNA from the HIGH fraction (Brinkman et al. 
2010) was prepared for bisulfite deep sequencing. DNA was first subjected to end-repair in a 
30 µl reaction containing 6 units T4 DNA polymerase, 2.5 units DNA Polymerase I (Large 
Klenow Fragment), 20 units T4 Polynucleotide Kinase (all New England Biolabs), dATP, 
dCTP, dGTP and dTTP (0.125 mM each), and 1x T4 Ligase buffer with ATP for 30 min at 
20°C. Illumina sequencing generates sequences corresponding to the 5’-ends of the input 
DNA fragments (see also Fig. 1a). Therefore, fill-in of 5’-overhangs did not alter sequenced 
DNA methylation patterns. Purification was performed using a standard 
phenol:chloroform:isoamyl alcohol (25:24:1) protocol and ethanol precipitation as described 
previously (Zachary D Smith et al. 2009). DNA was then adenylated in a 20 µl reaction 
containing 10 units Klenow Fragment (3’→5’ exo-) (New England Biolabs), 0.5 mM dATP 
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and 1x NEB buffer 2 for 30 min at 37°C. After phenol extraction and ethanol precipitation, 
Illumina genomic DNA adapters containing 5-methylcytosine instead of cytosine (atdbio, 
Southampton), preventing deamination during bisulfite conversion, were ligated. In a 20 µl 
reaction, DNA was incubated with 1.5 µM pre-annealed adapters, 2000 units T4 DNA Ligase 
(NEB) and 1x T4 Ligase buffer with ATP, for 16-20 h at 16°C. 
Adapter-ligated DNA fragments were subsequently purified by phenol extraction and 
ethanol precipitation, and size-selected on gel. 50 ng sheared and dephosphorylated E.coli 
K12 genomic DNA was added to adapter-ligated DNA as carrier during size-selection and 
bisulfite conversion. DNA was run on 2.5% Nusieve 3:1 Agarose (Lonza) gels. Lanes 
containing marker (50 bp ladder New England Biolabs) were stained with SYBR Green 
(Invitrogen), and size regions to be excised were marked with toothpicks. To obtain 80-280 bp 
(low) and 280-430 bp (high) insert sizes, adapter-ligated DNA fragments from 200-400 and 
400-550 bp, respectively, were excised. The Illumina adapters cause the fragments to run 
slower, presumably due to the forked structure, as has been described before (Zachary D 
Smith et al. 2009). Note that after PCR, dsDNA libraries appear at 140-340 bp and 340-490 
bp, in accordance with exact sizes. DNA was isolated from gel using the MinElute Gel 
Extraction kit (QIAGEN). The low and high libraries were kept separate in subsequent steps. 
Analytical PCRs were performed to check ligation efficiency and sizes of the libraries. 
Amplifications were performed in 10 µl reactions containing 0.3 µl template DNA (from 20 
µl eluted after size-selection), 0.5 units Pfu Turbo Cx Hotstart DNA Polymerase (Stratagene), 
Illumina primers LPX 1.1 and 2.1 (0.3 µM each), dNTPs (0.25 mM each), 1x Turbo Cx 
buffer, under the following thermocycler conditions: 94°C for 5 min,  n x (94°C for 30 s, 
65°C for 30 s, 72°C for 1 min) and 72°C for 7 min. We tested three different cycle numbers 
(n) –  10, 15 and 20 –  and analyzed PCR products on 4-20% TBE Criterion precast gels 
(BioRad) using SYBR Green staining. 
Adapter-ligated and size-selected DNA was subjected to two subsequent 5h bisulfite 
treatments using the EpiTect Bisulfite kit (QIAGEN) following the manufacturer's protocol 
for DNA isolated from FFPE tissue samples. After bisulfite conversion, analytical PCRs were 
performed as before to determine the minimum number of cycles required in the final 
amplification step for each sample. In this case, tested cycle numbers were several cycles 
higher as before bisulfite conversion; 15, 19 and 22 PCR cycles were performed. The 
minimum cycle number for final large-scale amplification was determined as the lowest cycle 
number that generated enough PCR product of the desired size range to be visualized on 
analytical gels as above. Large-scale amplification was performed in 8 reactions of 25 µl, 
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each containing 3 µl DNA (from 40 µl bisulfite-converted DNA, the remainder was stored at 
-80°C as back-up), 1.25 units Pfu Turbo Cx Hotstart DNA Polymerase (Stratagene), primer 
LPX 1.1 and 2.1 (0.3 µM each), dNTPs (0.25 mM each), 1x Turbo Cx buffer and 
thermocycler conditions as above. Amplified libraries were purified with the MinElute PCR 
Purification kit (QIAGEN), and subsequently purified from gel essentially as described 
above; whole gels were stained with SYBR Green and no carrier DNA was added. Final 
libraries were analysed on analytical 4-20% TBE Criterion precast gels (BioRad), and 
measured by Quant-iT dsDNA HS Assays (Invitrogen). The protocol for preparation of 
captured DNA for bisulfite deep sequencing was adapted from (Smith et al. 2009; Gu et al. 
2010, 2011). Sequence reads were generated on the Illumina Genome Analyzer IIx or the 
HiSeq2000 using a standard 36-base protocol. After sequencing low and high library reads 
were combined.
Bisulfite sequencing of PCR fragments
Cultured cells (SKNO-1) were either untreated or crosslinked directly in culture 
medium by the addition of 1% formaldehyde for 15 min. at room temperature. Chromatin 
harvesting, de-crosslinking and DNA isolation were done as described previously (Denissov 
et al. 2007). Bisulfite conversion was performed using the EpiTect Bisulfite kit (QIAGEN) 
following the manufacturer's standard protocol. For each sample, PCR amplicons of the 
appropriate size were excised from agarose gel, pooled, and subjected to end-repair as above. 
Pooled fragments were subsequently concatamerized by ligation in the presence of 17% 
PEG3350,   and sonicated using a Bioruptor (Diagenode) at high power for 30 min. in a final 
volume of 300 µl. The obtained DNA fragments were subjected to library preparation 
according the standard procedure (Illumina). Index sequences were introduced by using in-
house generated single-read adapters that contained a six-base barcode directly after the 
sequence primer binding site. The two samples (untreated and crosslinked/de-crosslinked) 
were pooled and sequenced on the Illumina Genome Analyzer IIx using a standard 36-base 
protocol.
ChIP-seq and MethylCap-seq data analysis
MethylCap peaks in HCT116 and H3K27me3 peaks in mES cells were called by 
MACS (Yong Zhang et al. 2008), with mfold=4 and pvalue=1e-06 and 1e-10, respectively. 
MethylCap LOW, MEDIUM and HIGH fractions (Brinkman et al. 2010) were used 
individually for peak calling, after which peaks were merged. Identification of H3K27me3 
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enriched regions (BLOCs) was performed using the RSEG algorithm (Song and Smith 2011), 
which models the read counts with a negative binomial distribution after correcting for the 
effect of genomic deadzones. Subsequently, it uses a two-state HMM for segmentation the 
genome into foreground domains and background domains. We used a binsize of 500 bp in 
combination with default RSEG settings. These include that the posterior probability of each 
bin obtained by HMM decoding is larger than 0.95, and that the mean read counts within a 
region is above the top 90% percentile of foreground emission distribution.  BLOCs within 20 
kb proximity were merged, and BLOCs smaller than 20 kb were discarded.   
ChIP-BS-seq and MethylCap-BS-seq data analysis
Initial data processing and base-calling was done using the Illumina pipeline software. 
Mapping of bisulfite-converted sequence reads was done using a custom-made pipeline using 
a strategy similar to that in Lister et al. (Lister et al. 2009). To reduce PCR artifacts, a 
maximum of three identical sequence reads was allowed. To perform mapping independently 
of DNA methylation status, sequence reads were in silico bisulfite-converted (C to T), and 
subsequently mapped to two different in silico converted hg18 genome sequences; one C to T 
converted genome and one G to A converted genome. Reads mapping to both genomes were 
discarded, which typically represented a very minor fraction of all reads. Mapping was done 
using the Burrows-Wheeler Aligner (BWA) (Heng Li and Durbin 2010), with default settings 
allowing a single mismatch. Percentages of uniquely mapped reads ranged from 78% to 50% 
for the 80-280 bp and 280-430 bp libraries, respectively (see Suppl. Table 1 for details). The 
obtained mapping positions were used to align unconverted sequence reads with their 
corresponding unconverted genomic sequence and to subsequently determine the methylation 
status of each sequenced cytosine within a CpG context, both on the forward strand as well as 
on the reverse strand. The mapping and CpG methylation scoring procedure was driven by a 
custom-generated Perl script. Further data analysis was done using in-house generated scripts 
written in LINUX shell, Python, Perl, and R. Gene annotations were based on RefSeq (hg18), 
CpG islands annotations were based on UCSC (http://genome.ucsc.edu/) 
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Data access
The data generated for this work have been deposited in NCBI's Gene Expression 
Omnibus and are accessible through GEO Series accession number GSE28254 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE28254). 
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Figure Legends
Figure 1. Integration of capturing methods and bisulfite deep sequencing: ChIP-BS-seq and 
MethylCap-BS-seq. (A) Schematic outline of the ChIP-BS-seq and MethylCap-BS-seq 
procedures. Capturing of genomic regions of interest is achieved by the MethylCap procedure 
or ChIP with an antibody of interest. Captured DNA is processed as indicated. Shown 
intermediate products and final PCR fragments indicate the fate of unmethylated as well as 
methylated cytosines throughout the procedure. (B) Examples of conventional MethylCap-seq 
and MethylCap-BS-seq data of normal (N) and tumor (T) colon tissues. For each covered 
CpG, percentage methylation as derived from the MethylCap-BS-seq data is indicated by 
color (yellow, 0%; blue, 100%). CpG islands and a CpG density profile (CpG/bp) are shown 
in green. (C) Average profiles of DNA methylation and coverage in MethylCap peaks of 
normal colon tissue, as determined by MethylCap-BS-seq. Percentage DNA methylation, 
blue; CpG coverage, magenta; read density, brown. (D) MethylCap-BS-seq analysis of 
differentially methylated regions from normal/tumor colon tissue. Regions that gain DNA 
methylation in tumor tissue show increased CpG coverage (x-axis) and read-density (y-axis). 
Color-code depicts absolute changes in percent methylation of these regions, as determined by 
bisulfite sequencing. Blue, increase; yellow, decrease. 
Figure 2. H3K27me3 enriched CpG island promoters are devoid of DNA methylation. (A,B) 
Examples of H3K27me3 ChIP-BS-seq data of HCT116 cells. H3K27me3 ChIP-BS-seq 
profiles are shown, as well as the derived DNA methylation data per covered CpG and per 
200-bp window. Percentage methylation is color coded as in Figure 1B. (C) Histograms 
showing the distribution of mean methylation in 300 bp windows throughout H3K27me3 
enriched regions, as derived from H3K27me3 ChIP-BS-seq results. Windows were 
categorized according to functional genomic elements (intergenic, intron, exon, non-CpG 
island promoter or CpG island promoter). (D) Average profiles of DNA methylation (blue), 
H3K27me3 (red), and CpG density (green) in regions flanking H3K27me3-enriched CpG 
islands, as determined from H3K27me3 ChIP-BS-seq data.
Figure 3. H3K27me3 is locally depleted at hypermethylated CpG islands. (A) Examples of 
the genome-wide H3K27me3 ChIP-seq and MethylCap-seq data, demonstrating 
hypermethylated CpG islands within H3K27me3 BLOCs, and concomitant local depletion of 
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H3K27me3. H3K27me3-enriched BLOCs and MethylCap peaks are indicated as red and blue 
rectangles, respectively. (B) Density maps of MethylCap-seq and H3K27me3 ChIP-seq read 
densities in 20-kb regions surrounding MethylCap peaks that reside in H3K27me3 BLOCs 
and overlap with CpG islands.  
Figure 4. Localized peaks of H3K27me3 in wild-type mES cells over CpG islands. (A) 
Screenshots of localized H3K27me3 peaks (red). Per covered CpG, percentage methylation as 
derived from the H3K27me3-BS-seq data is indicated in color. (B, C) Average profiles of 
DNA methylation (blue), H3K27me3 (red), and CpG density (green) in H3K27me3 peaks 
over CpG islands, as determined from H3K27me3-ChIP-BS-seq. (D) Histograms showing the 
distribution of methylation in 300 bp windows through H3K27me3 peaks, as inferred from 
H3K27me3 ChIP-BS-seq. Windows were categorized according to CpG density. (E) 
H3K27me3 changes in CpG islands that were either hypermethylated (>90%, left) or 
hypomethylated (<10%, right) in wild-type mES cells. Readcounts shown are from 
conventional H3K27me3 ChIP.
Figure 5. Changes in H3K27me3 patterns upon loss of DNA methylation in Dnmt triple-
knockout (TKO) mES cells. (A) Examples of H3K27me3 BLOCs appearing in TKO cells, 
and concomitant loss of H3K27me3 in localized peaks. Per covered CpG, percentage 
methylation as derived from H3K27me3-ChIP-BS-seq is indicated in color. (B) Scatterplot of 
H3K27me3 changes in peaks (x-axis) vs. BLOCs (y-axis). H3K27me3 peaks were matched 
against BLOCs in which they reside. I-IV indicate the four quadrants of the plot, as 
determined by log2 fold changes deviating from zero. (C) Histograms of percent DNA 
methylation in the BLOCs of each quadrant of (B), as deduced from H3K27me3-ChIP-BS-
seq in wild-type mES cells. (D) Density  maps  of H3K27me3 through BLOC transition 
regions detected in TKO mES cells. Average profiles are shown on top.  
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Supplementary Figure 1. (A) Scatter-plot showing MethylCap versus MethylCap-BS-seq 
read densities within 5 kb windows covering the genome. (B) Additional examples of normal 
MethylCap-seq and MethylCap-BS-seq data of normal (N) and tumor (T) colon tissues. Per 
covered CpG, percentage methylation as derived from the MethylCap-BS-seq data is 
indicated in color. (C) Histograms showing the distribution of methylation in MethylCap 
peaks, as derived from MethylCap-BS-seq of normal and colon tissue.   
Supplementary Figure 2. (A) Scatter-plot showing H3K27me3 ChIP-seq versus ChIP-BS-
seq read densities within 5 kb windows covering the genome.  (B) Bisulfite sequencing of 
individual PCR fragments amplified from genomic DNA from either untreated or 
crosslinked/decrosslinked cells (SKNO-1) as in ChIP. CpGs were sequenced to a median 
coverage of over 300-fold (see Methods). (C) Example of H3K27me3 ChIP-BS-seq data of 
HCT116 cells, showing DNA methylation throughout H3K27me3 BLOCs. Percentage 
methylation is color coded. (D) Examples of H3K27me3 ChIP-BS-seq data of HCT116 cells, 
displaying DNA hypomethylation within H3K27me3-enriched CpG islands. (E) Histograms 
showing the distribution of methylation in 300 bp windows throughout H3K27me3 enriched 
regions, as established from H3K27me3 ChIP-BS-seq results. Windows were categorized 
according to CpG density. 
Supplementary Figure 3. (A) Boxplot showing expression levels of genes contained within 
H3K27me3 BLOCs and genes outside BLOCs. RPKM, Reads Per Kilobase of exon model 
per Million mapped reads. The p-value was calculated using the Mann-Whitney U test. (B) 
Density plot showing the distribution of H3K27me3 BLOCs sizes. (C) Upper panel, 0.7-Mb 
overview of the genome-wide H3K27me3 ChIP-seq and MethylCap-seq data of HCT116 
cells. Positions of H3K27me3 BLOCs and MethylCap peaks are indicated as red and blue 
rectangles, respectively. RNA-seq data are included (black profile). Middle and lower panel, 
additional examples of H3K27me3 ChIP-seq and MethylCap–seq data demonstrating 
hypermethylated CpG islands within H3K27me3 BLOCs, and concomitant local depletion of 
H3K27me3. (D) Boxplot showing that MethylCap peaks are not associated with DNaseI 
hypersensitivity. DNaseI hypersensitivity was measured within DNaseI peaks (defined by 
ENCODE), MethylCap peaks and random genomic regions of equal size. DNaseI-seq data for 
HCT116 cells were retrieved from ENCODE (DNaseI Hypersensitivity by Digital DNaseI 
from ENCODE/University of Washington). 
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Supplementary Figure 4. (A) Density plot showing the length distribution of H3K27me3 
BLOCs and localized H3K27me3 peaks in mES cells. (B) Genomic distribution of localized 
H3K27me3 peaks in mES cells. TSS, transcription start sites (here defined the region from 
-500 to +500 bp). 
Supplementary Figure 5. H3K9me3 peaks of mES cells are associated with DNA 
hypermethylation. (A) Screenshots of H3K9me3 peaks (orange) at  H19 and the  Meg3 and 
Gbr10 genes. The H3K9me3 peak upstream of H19 colocalizes with the imprinting control 
region (ICR) upstream of H19 (Bell and Felsenfeld 2000; Hark et al. 2000; Kanduri et al. 
2000). Per covered CpG, percentage methylation as derived from the H3K9-BS-seq data is 
indicated in color. (B) Histograms showing the distribution of methylation in 300 bp windows 
through peaks of H3K9me3 in wild-type mES cells, and peaks of  H3K27me3 in  wild-type 
and TKO mES cells, as inferred from ChIP-BS-seq.
Supplementary Figure 6. ChIP-qPCR validation of observed changes in H3K27me3 peaks 
(decrease) and H3K27me3 BLOCs (increase) in TKO mES cells. 
Supplementary Figure 7. Megabase-scale genome profiles reveal resemblance between 
H3K27me3 of TKO mES cells and MethylCap DNA methylation of wild-type mES cells. A 
0.5-Mb windowing was applied over the complete mouse genome, and read counts within 
these windows were calculated to generate megabase-scale profiles for H3K27me3 and 
MethylCap. (A) Profiles for chromosomes 1, 3, and 10. Grey highlights represent regions 
with highest correlation between H3K27me3-TKO and MethylCap-wild-type (increase of at 
least 0.4, to a minimum of 0.8, Pearson correlation). (B) Example of a 36-Mb region in 
chr10qD, as indicated by the red arrow in (A). (C) Overall Pearson correlation between 
megabase-scale genome profiles.
Supplementary Figure 8.  (A) Boxplot of gene expression changes in wild-type and TKO 
mES cells, inside and outside of H3K27me3 BLOCs. RPKM, Reads Per Kilobase of exon 
model per Million mapped reads. (B) MA-plots of gene expression changes in TKO relative 
to wild-type mES cells. Blue, unchanged genes; red, upregulated genes; green, downregulated 
genes. Deregulated genes were detected using the DESeq package (Anders and Huber 2010) 
at an FDR of 0.05 and with an additional threshold of 2-fold change. 
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Supplementary Figure 4
B H3K27me3 peaks mES cellsA
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Table S1. Number of sequenced reads, mapped reads, and covered CpGs
total reads mapped reads %mapped CpGs covered
8,611,562 5,884,046 68.3 NA
8,093,347 5,648,639 69.8 NA
25,019,403 12,263,052 49.0 4,608,717
20,637,230 11,514,170 55.8 4,266,794
HCT116 MethylCap LOW 8,391,253 5,649,714 67.3 NA
HCT116 MethylCap MEDIUM 7,238,849 4,810,256 66.5 NA
HCT116 MethylCap HIGH 8,410,985 5,088,619 60.5 NA
14,292,629 11,356,014 79.5 NA
79,361,626 53,319,494 67.2 7,404,348
24,340,182 19,494,155 80.1 NA
30,326,735 20,700,636 68.3 NA
100,485,300 74,612,214 74.25 NA
118,130,215 67,493,142 57.1 6,889,510
99,556,666 62,365,980 62.64 NA
120,490,814 58,632,732 48.7 7,255,564
mouse ES E14 MethylCap MEDIUM 13,286,203 10,414,439 78.39 NA
mouse ES E14 MethylCap HIGH 15,410,526 7,476,739 48.52 NA
colon normal HIGH MethylCap-seq
colon tumor HIGH MethylCap-seq
colon normal HIGH MethyCap-BS-seq





mouse ES V6.5 H3K27me3 ChIP-seq
mouse ES V6.5 H3K27me3 ChIP-BS-seq
mouse ES Dnmt TKO H3K27me3 ChIP-seq
mouse ES Dnmt TKO  H3K27me3 ChIP-BS-seq
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Table S2. Primer sequences used in this study
name Sequence (5' → 3') chromosome position (mm9)
TCGGAGATGTCTGCAGTGTC chr10 115022166 115026860
GACATCAAAGGGCGTTGTTT
AACCCCTCACTGACAACCAG chr10 115140959 115148010
AGCCAAAGCCAAGGGTATTT
CAAAGGTCCTTGCGTCTCTC chr10 115455488 115456261
GCAGAAAAGAGGCAGTGGTC
CAAAGGTCCTTGCGTCTCTC chr15 12343378 12349420
GCAGAAAAGAGGCAGTGGTC
GCCGTAAGTGCATCCAAAAT chr15 12667169 12669221
GCTGGTAGGTGTTGGGAAAA
TGTTGTGTTTGGCTCCCATA chr17 50582892 50586740
GCTGTCCAAAACCTCCACAT
GCATTGGGAAAGAATGGAGA chr17 50649198 50650782
GTCCTACCCAGGCAGGTACA
TCAAGTGGCAGAATGCTTTG chr3 51636919 51649777
CCATCCCATCCGTAAATGTC
GTGGTTGGCAAGCATTTTCT chr3 51907891 51908829
GCGGCATAAACACCAAAACT
GTGAGATGCTTGCAGGACAA chr3 153636629 153639293
TCATCATTAGCGGGGAGAAC
AGTAAGCGAGGGCATTCAGA chr3 153713839 153717821
CCTCCCATTTCTTGTTCCAA
GTTCTCCATGGCACAAACCT chr4 46895498 46900487
TGGAAGTTGACGTGGGTGTA
ACCCCAGGCAAAGTAGTCCT chr4 47004950 47005956
GTCAGGCTTTGGGATGTTGT
CACTGGGACCTTTGATTCGT chr5 77084553 77086920
AGTCTACCGGGCCTTTTGAT
AGCCTGACCTTCCAGTCTCA chr5 77190576 77196271
CATCATACAGGGTGGCTGTG
AGTCCACGACCACTTTGGAC chr5 77285018 77288440
TCTTCTTCTGTTCGGCCTGT
ACTGCCCCATTCAATGTCTC chr5 143668353 143668896
GATGCTGACCCTCATCCACT
GAGACCTGAATGCTGCTTCC chr6 125115415 125116334
ACCGAAGAACAACGAGGAGA
TCCCGTAACTTCGGTAAACG chr7 37476810 37480713
AACAGCAGAGGGACAGGAGA
ACCTTGACCTCCTCCCAACT chr6 87283928 87285395
TGGATCTGTGCCTCAGTCAG
ACCTTCATTGCCTGGACAAC chr6 87176363 87178714
CACCCTCTGCTCTGTCTTCC
TCTTGCTTGAAGAGCAGCAA chr6 99469056 99470564
ACCCAGGACACTGCAATAGG
CCCTGCTTTGAAGTGAGAGG chr6 99083878 99088626
ACAGGTTGCAGGGTATGGAG
name Sequence (5' → 3') chromosome position (hg18)
GTGTGGTTTAATAGTAATTTGTAGAA chr22 23159463 23159620
AAACAAACAATAAAAAAACAACC
ATTATGGATTTGATTTTTGTTTAG chr1 25130744 25130945
AAAATTCAATAAAAAACCTTTACC
GATTGGGGTTTAGAGAGTAGAGTGA chr19 51491811 51492004
AAAAAAAACTTAAAAAAACAAAAAAAA
TAGTTTTAGTTGGTTGGATATGTTG chr17 53710330 53710500
ATTCTACCTAAACACCTTCCTTACC
TAGTAGGGGTTTAATTAGAGGTGGT chr3 58197615 58197853
AAAACCCCCAAATCCTCTAAAC
TTTGTTTGTATGGGGTAGGTTTTTA chr20 59261339 59261528
ACCCCCAAACCTTAAACAAAA
ATTTTATTTAGAGGTTAATAGGTTTTAGTT chr20 60374980 60375279
CATTTTAAAAACCCAAAAAAACAC
GTTTTAGGGTATAAATAGGTGTGGAGTT chr8 70906653 70906773
CCCTACCAAATCCAAAAATTAAAC
TTAGGAATTTTTAAAGATTTGAATT chr5 76286076 76286241
CACTAAAAACAACCTCTATACTCTC
GTATGGATTAGTAAAGTAAAGGTAG chr3 123431774 123431944
TACTAAAACAAAAAAATCTAAACTC
TTTTAATTTAGTGTGGGGGAGTAAG chr7 155011667 155011853
TATTTAAAAATATCCCCTACCAACC
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